Ángel Santiago

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 6

Top Topics

Plasmodium Falciparum

Molecular Docking

Cognitive Decline

Binding Protein

Top Venues

Molecules (Basel, Switzerland)

Chemical biology & drug design

Journal of chemical information and modeling

This page only lists publications with an associated author ORCID identifier.

Publications

Ángel Santiago, Dulce C Guzmán-Ocampo, Rodrigo Aguayo-Ortiz, Laura Domínguez
Characterizing the Chemical Space of γ-Secretase Inhibitors and Modulators. ACS chemical neuroscience 12 (15) (2021)
Ángel Santiago, Rodrigo Said Razo-Hernández, Nina Pastor
Revealing the Structural Contributions to Thermal Adaptation of the TATA-Box Binding Protein: Molecular Dynamics and QSPR Analyses. Journal of chemical information and modeling 60 (2) (2020)
Berto Tejera, Raúl E López, Paloma Hidalgo, Reinier Cárdenas, Grisel Ballesteros, Lina Rivillas, Leidys French, Carlos Amero, Nina Pastor, Ángel Santiago, Peter Groitl, Thomas Dobner, Ramón A González
The human adenovirus type 5 E1B 55kDa protein interacts with RNA promoting timely DNA replication and viral late mRNA metabolism. PloS one 14 (4) (2019)
Ángel Santiago, Rodrigo Said Razo-Hernández, Berto Tejera
The TATA-binding Protein DNA-binding domain of eukaryotic parasites is a potentially druggable target. Chemical biology & drug design 95 (1) (2019)
Erika Tovar-Gudiño, Juan Alberto Guevara-Salazar, José Raúl Bahena-Herrera, José Guadalupe Trujillo-Ferrara, Zuleyma Martínez-Campos, Rodrigo Said Razo-Hernández, Ángel Santiago, Berto Tejera, Mario Fernández-Zertuche
Novel-Substituted Heterocyclic GABA Analogues. Enzymatic Activity against the GABA-AT Enzyme from Pseudomonas fluorescens and In Silico Molecular Modeling. Molecules (Basel, Switzerland) 23 (5) (2018)
Josué Rodríguez-Lozada, Erika Tovar-Gudiño, Juan Alberto Guevara-Salazar, Rodrigo Said Razo-Hernández, Ángel Santiago, Berto Tejera, Mario Fernández-Zertuche
QSAR and Molecular Docking Studies of the Inhibitory Activity of Novel Heterocyclic GABA Analogues over GABA-AT. Molecules (Basel, Switzerland) 23 (11) (2018)